why choose us

First received: August 22, 2022

Clinical Trial: The Impact of "First-Line" Rhythm Therapy on AF Progression

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Atrial Fibrillation
Atrial Fibrillation New Onset
Atrial Fibrillation, Persistent
Arr

Study Type: Interventional


Official Title: The Impact of "First-Line" Rhythm Therapy on AF Progression

Brief Summary: The PROGRESSIVE-AF Trial is a national, multi-center randomized controlled trial comparing early ("first-line") catheter-based pulmonary vein isolation (PVI) using cryothermal energy to first-line anti-arrhythmic drug therapy. The aim of the trial is to evaluate if the initial treatment choice (ablation vs. pharmacotherapy) influences AF disease progression, as measured by continuous cardiac monitoring. The outcomes of interest are disease progression, quality of life, and healthcare utilisation. The targeted…

Read more